Elena N. Atochina‐Vasserman

4.5k total citations · 4 hit papers
83 papers, 3.4k citations indexed

About

Elena N. Atochina‐Vasserman is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Elena N. Atochina‐Vasserman has authored 83 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Elena N. Atochina‐Vasserman's work include Neonatal Respiratory Health Research (35 papers), Respiratory Support and Mechanisms (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers). Elena N. Atochina‐Vasserman is often cited by papers focused on Neonatal Respiratory Health Research (35 papers), Respiratory Support and Mechanisms (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers). Elena N. Atochina‐Vasserman collaborates with scholars based in United States, Russia and United Kingdom. Elena N. Atochina‐Vasserman's co-authors include Michael F. Beers, Andrew J. Gow, Vladimir R. Muzykantov, Drew Weissman, S M Danilov, Yaniv Tomer, Seth Thomas Scanlon, Angela M. Preston, James M. Beck and Changjiang Guo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Elena N. Atochina‐Vasserman

82 papers receiving 3.4k citations

Hit Papers

One-Component Multifunctional Sequence-Defined Ionizable ... 2021 2026 2022 2024 2021 2024 2021 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
    2021 123 citations Elena N. Atochina‐Vasserman, Nathan Ona et al. profile →
  2. mRNA-based therapeutics: looking beyond COVID-19 vaccines
    2024 112 citations Hamideh Parhiz, Elena N. Atochina‐Vasserman et al. The Lancet profile →
  3. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
    2021 93 citations David R. Martinez, Alexandra Schäfer et al. Science profile →
  4. The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
    2022 87 citations Elena N. Atochina‐Vasserman, Nathan Ona et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena N. Atochina‐Vasserman United States 38 1.3k 1.2k 640 422 270 83 3.4k
Rainer Wiewrodt Germany 35 983 0.8× 1.7k 1.4× 239 0.4× 628 1.5× 204 0.8× 97 3.8k
Roy R. Hantgan United States 34 875 0.7× 1.5k 1.3× 326 0.5× 277 0.7× 225 0.8× 89 3.8k
Ralf Schubert Germany 34 712 0.5× 1.3k 1.2× 618 1.0× 641 1.5× 139 0.5× 192 4.0k
Yang Xia China 38 849 0.7× 2.1k 1.8× 309 0.5× 707 1.7× 135 0.5× 195 4.5k
Fabrizio Marcucci Italy 36 464 0.4× 1.2k 1.0× 1.1k 1.7× 744 1.8× 243 0.9× 141 4.6k
Shaopeng Yuan China 30 708 0.5× 1.8k 1.6× 787 1.2× 1.5k 3.6× 119 0.4× 61 4.7k
Jaehyung Cho United States 31 481 0.4× 1.1k 1.0× 291 0.5× 765 1.8× 259 1.0× 84 3.4k
Hanno Huwer Germany 33 835 0.6× 1.2k 1.0× 173 0.3× 362 0.9× 314 1.2× 99 3.2k
Monika Dzieciątkowska United States 39 323 0.2× 1.5k 1.3× 923 1.4× 348 0.8× 334 1.2× 157 4.2k
V. Courtney Broaddus United States 38 1.9k 1.5× 1.3k 1.2× 158 0.2× 615 1.5× 75 0.3× 80 4.1k

Countries citing papers authored by Elena N. Atochina‐Vasserman

Since Specialization
Citations

This map shows the geographic impact of Elena N. Atochina‐Vasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena N. Atochina‐Vasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena N. Atochina‐Vasserman more than expected).

Fields of papers citing papers by Elena N. Atochina‐Vasserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena N. Atochina‐Vasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena N. Atochina‐Vasserman. The network helps show where Elena N. Atochina‐Vasserman may publish in the future.

Co-authorship network of co-authors of Elena N. Atochina‐Vasserman

This figure shows the co-authorship network connecting the top 25 collaborators of Elena N. Atochina‐Vasserman. A scholar is included among the top collaborators of Elena N. Atochina‐Vasserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena N. Atochina‐Vasserman. Elena N. Atochina‐Vasserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parhiz, Hamideh, Elena N. Atochina‐Vasserman, & Drew Weissman. (2024). mRNA-based therapeutics: looking beyond COVID-19 vaccines. The Lancet. 403(10432). 1192–1204. 112 indexed citations breakdown →
2.
Atochina‐Vasserman, Elena N., Lisa C. Lindesmith, Carmen Mirabelli, et al.. (2024). Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection. npj Vaccines. 9(1). 182–182. 4 indexed citations
3.
Martinez, David R., Alexandra Schäfer, Sarah R. Leist, et al.. (2021). Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 373(6558). 991–998. 93 indexed citations breakdown →
4.
Guo, Changjiang, Elena N. Atochina‐Vasserman, Elena Abramova, et al.. (2019). Surfactant protein-D modulation of pulmonary macrophage phenotype is controlled byS-nitrosylation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(5). L539–L549. 9 indexed citations
5.
Himes, Blanca E., Lurong Lian, Maya Shumyatcher, et al.. (2018). Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells. PLoS ONE. 13(5). e0197105–e0197105. 5 indexed citations
6.
Botelho, D., Bey Fen Leo, Christopher B. Massa, et al.. (2018). Exposure to Silver Nanospheres Leads to Altered Respiratory Mechanics and Delayed Immune Response in an in Vivo Murine Model. Frontiers in Pharmacology. 9. 213–213. 12 indexed citations
7.
Guo, Changjiang, et al.. (2015). Role of NOS2 in pulmonary injury and repair in response to bleomycin. Free Radical Biology and Medicine. 91. 293–301. 33 indexed citations
8.
Atochina‐Vasserman, Elena N., Changjiang Guo, Elena Abramova, et al.. (2014). Surfactant Dysfunction and Lung Inflammation in the Female Mouse Model of Lymphangioleiomyomatosis. American Journal of Respiratory Cell and Molecular Biology. 53(1). 96–104. 11 indexed citations
9.
Knudsen, Lars, Elena N. Atochina‐Vasserman, Changjiang Guo, et al.. (2014). NOS2 Is Critical to the Development of Emphysema in Sftpd Deficient Mice but Does Not Affect Surfactant Homeostasis. PLoS ONE. 9(1). e85722–e85722. 15 indexed citations
10.
Atochina‐Vasserman, Elena N., et al.. (2013). Statins in Lymphangioleiomyomatosis. Simvastatin and Atorvastatin Induce Differential Effects on tuberous sclerosis complex 2 –Null Cell Growth and Signaling. American Journal of Respiratory Cell and Molecular Biology. 49(5). 704–709. 24 indexed citations
11.
Atochina‐Vasserman, Elena N., Sandra R. Bates, Peggy Zhang, et al.. (2011). Early Alveolar Epithelial Dysfunction Promotes Lung Inflammation in a Mouse Model of Hermansky-Pudlak Syndrome. American Journal of Respiratory and Critical Care Medicine. 184(4). 449–458. 49 indexed citations
12.
Atochina‐Vasserman, Elena N.. (2011). S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(6). 763–769. 34 indexed citations
13.
Atochina‐Vasserman, Elena N., Carla Winkler, Frank Schaumann, et al.. (2010). Segmental Allergen Challenge Alters Multimeric Structure and Function of Surfactant Protein D in Humans. American Journal of Respiratory and Critical Care Medicine. 183(7). 856–864. 36 indexed citations
14.
Jain, Deepika, et al.. (2008). Surfactant Protein D Protects against Acute Hyperoxic Lung Injury. American Journal of Respiratory and Critical Care Medicine. 178(8). 805–813. 42 indexed citations
15.
Atochina‐Vasserman, Elena N., et al.. (2007). Selective Inhibition of Inducible NO Synthase Activity In Vivo Reverses Inflammatory Abnormalities in Surfactant Protein D-Deficient Mice. The Journal of Immunology. 179(12). 8090–8097. 37 indexed citations
16.
Haczku, Angela, Richard Y. Cao, G. Vass, et al.. (2006). IL-4 and IL-13 Form a Negative Feedback Circuit with Surfactant Protein-D in the Allergic Airway Response. The Journal of Immunology. 176(6). 3557–3565. 73 indexed citations
17.
Casey, John, Jennifer Kaplan, Elena N. Atochina‐Vasserman, et al.. (2005). Alveolar Surfactant Protein D Content Modulates Bleomycin-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 172(7). 869–877. 46 indexed citations
18.
Atochina‐Vasserman, Elena N., James M. Beck, Seth Thomas Scanlon, Angela M. Preston, & Michael F. Beers. (2001). Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D. Journal of Laboratory and Clinical Medicine. 137(6). 429–439. 48 indexed citations
19.
Atochina‐Vasserman, Elena N., et al.. (1997). Normoxic Lung Ischemia/Reperfusion Accelerates Shedding of Angiotensin Converting Enzyme from the Pulmonary Endothelium. American Journal of Respiratory and Critical Care Medicine. 156(4). 1114–1119. 38 indexed citations
20.
Danilov, Sergei M., Vladimir R. Muzykantov, А. В. Мартынов, Ivan Yu. Sakharov, & Elena N. Atochina‐Vasserman. (1988). [Specific accumulation of monoclonal antibodies against angiotensin-converting enzyme in the rat lung].. PubMed. 301(4). 1003–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rainer Wiewrodt Breakdown of academic impact, for papers by Roy R. Hantgan Breakdown of academic impact, for papers by Ralf Schubert Breakdown of academic impact, for papers by Yang Xia Breakdown of academic impact, for papers by Fabrizio Marcucci Breakdown of academic impact, for papers by Shaopeng Yuan Breakdown of academic impact, for papers by Jaehyung Cho Breakdown of academic impact, for papers by Hanno Huwer Breakdown of academic impact, for papers by Monika Dzieciątkowska Breakdown of academic impact, for papers by V. Courtney Broaddus
Rankless by CCL
2026